Vyepti 100mg/1ml Vial Single Dose is administered by intravenous infusion, helps prevent migraine attacks and reduces the number of migraine days in adults who experience migraines at least 4 days per month.
Vyepti ingredients
Vyepti contains the active ingredient eptinezumab, which blocks the activity of calcitonin gene-related peptide (CGRP) — a molecule found at elevated levels in people with migraine.
Veypti uses
-
Vyepti is used for the prevention of migraine in adults who experience migraine symptoms at least 4 days per month.
-
It helps reduce the number of migraine days and improve quality of life. Its preventive effect begins the day after administration.
Dosage of Vyepti 100 mg/1 mL
Vyepti is administered by intravenous infusion over 30 minutes by a healthcare professional.
-
The recommended dose is 100 mg every 12 weeks.
-
Some patients may require a 300 mg dose every 12 weeks.
Vyepti side effects
Possible side effects include:
-
Sore throat
-
Nasal congestion
-
Fatigue
Contraindications
Vyepti should not be used in:
-
Patients with hypersensitivity to its ingredients
-
Children and adolescents under 18 years of age
Warnings and Precautions
Use with caution and consult a doctor before using Vyepti, especially in cases of:
-
Pregnancy and breastfeeding
-
Cardiovascular diseases
Storage Instructions
-
Keep out of the reach of children.
-
Store in a refrigerator at 2–8°C.
-
Do not freeze.
-
If removed from the refrigerator, it may be kept at room temperature (25°C) in its original carton for up to 7 days; discard if not used afterward.
After dilution, the solution may be stored at room temperature (25°C) or in a refrigerator (2–8°C) and must be used within 8 hours. -
Store in the original package, protected from light.